Not applicableNot Yet RecruitingNCT07525024What this trial is testingKSD-101 in Patients With EBV-associated Hematological MalignanciesWho this might be right forEBV Associated Lymphoid Neoplasms Ruijin Hospital 80
Testing effectiveness (Phase 2)Study completedNCT02553343What this trial is testingThe Safety and Immunogenicity of High-Dose Quadrivalent Influenza Vaccine in Subjects Aged 65 Years and OlderWho this might be right forInfluenza Sanofi Pasteur, a Sanofi Company 792
Early research (Phase 1)UnknownNCT04268420What this trial is testingA Trial For The Study of Falciparum Malaria Protein 013 Administered Via Intramuscular Injection in Healthy AdultsWho this might be right forVaccine Reaction U.S. Army Medical Research and Development Command 46
Post-approval studies (Phase 4)Active Not RecruitingNCT07266558What this trial is testingEvaluate the Efficacy and Safety of mRNA-1283 and mRNA-1273 in Participants 50 to 64 Years of Age Without High-Risk Conditions for Severe Coronavirus Disease 2019 (COVID-19)Who this might be right forSARS-CoV-2 ModernaTX, Inc. 30,000
Not applicableStudy completedNCT02819115What this trial is testingCohort Study to Evaluate Safety and Immunogenicity of Butantan Seasonal Influenza VaccineWho this might be right forInfluenza Butantan Institute 63
Not applicableStudy completedNCT01062074What this trial is testingGARDASIL Reexamination Study (V501-059)Who this might be right forHuman Papillomavirus (HPV) Infection Merck Sharp & Dohme LLC 3,605
Large-scale testing (Phase 3)Study completedNCT01000974What this trial is testingConsistency & Immunogenicity Study of 3 Lots of GSK's Hib Conjugate Vaccine Versus ActHIB & Pentacel in Healthy InfantsWho this might be right forHaemophilus Influenzae Type b GlaxoSmithKline 4,003
Large-scale testing (Phase 3)Ended earlyNCT04605159What this trial is testingA Phase III, Double-blind Study to Assess Safety and Efficacy of an RSV Maternal Unadjuvanted Vaccine, in Pregnant Women and Infants Born to Vaccinated MothersWho this might be right forRespiratory Syncytial Virus Infections GlaxoSmithKline 11,194
Early research (Phase 1)Looking for participantsNCT07107516What this trial is testingPhase 1b Ascending Dose Study of PanChol in Healthy VolunteersWho this might be right forCholera Vaccination Reaction Centre for Infectious Disease Research in Zambia 32
Testing effectiveness (Phase 2)Study completedNCT03604406What this trial is testingThe Immunogenicity and Safety of Zostavax® and Shingrix® in Rheumatoid Arthritis Patients Using AbataceptWho this might be right forHerpes ZosterInflammatory DiseaseRheumatoid Arthritis Kevin Winthrop 154
Early research (Phase 1)Study completedNCT00001052What this trial is testingA Phase I, Multicenter, Randomized, Double-Blind, Placebo-Controlled HIV-1 Vaccine Trial to Evaluate the Safety and Immunogenicity of MN Recombinant Soluble gp120/HIV-1 (rsgp120/HIV-1) (Genentech) in Combination With QS21 Adjuvant and/or Alum in Healthy AdultsWho this might be right forHIV Infections National Institute of Allergy and Infectious Diseases (NIAID) 110
Post-approval studies (Phase 4)Study completedNCT01857297What this trial is testingAssess the Immunogenicity and Safety of CSL's 2013/2014 Formulation of Enzira® Vaccine in Healthy VolunteersWho this might be right forInfluenza, Human Seqirus 120
Large-scale testing (Phase 3)Study completedNCT05386810What this trial is testingSafety of Sabin Inactivated Poliovirus Vaccine in Adults, Children and Infants and Lot Consistency Immunogenicity, and Safety of the msIPV in 2 Months Old InfantsWho this might be right forPoliomyelitis Sinovac Biotech Co., Ltd 1,572
Early research (Phase 1)Study completedNCT02354404What this trial is testingClinical Trial of Ebola Vaccines cAd3-EBO, cAd3-EBOZ and MVA-EbolaZ in Healthy Adults in UgandaWho this might be right forHemorrhagic Fever, Ebola National Institute of Allergy and Infectious Diseases (NIAID) 90
Large-scale testing (Phase 3)Study completedNCT01226953What this trial is testingImmunogenicity and Safety of a Booster Dose of Monovalent Glycoprotein-Conjugated (Diptheria Toxin -CRM197) Hib Vaccine in 365-569 Days Old Healthy InfantsWho this might be right forHaemophilus Influenzae Type b (Hib) Infection Novartis Vaccines 660
Not applicableStudy completedNCT00996853What this trial is testingPost-Authorization Safety Study of GSK Biologicals' Pandemic Influenza Vaccine (H1N1) in the United KingdomWho this might be right forInfluenza GlaxoSmithKline 9,206
Post-approval studies (Phase 4)Study completedNCT05161845What this trial is testingClinical Trial of Measles, Mumps and Rubella Combined Vaccine, LiveWho this might be right forImmunotoxicityVaccine Shanghai Institute Of Biological Products 1,068
Large-scale testing (Phase 3)Study completedNCT00420745What this trial is testingTo Assess Safety, Reactogenicity & Immunogenicity of 2 Doses of GSK's Oral Human Rotavirus Vaccine in Pre-Term InfantsWho this might be right forInfections, Rotavirus GlaxoSmithKline 1,009
Large-scale testing (Phase 3)Study completedNCT00605085What this trial is testingSafety and Tolerability of the Japanese Encephalitis Vaccine IC51Who this might be right forJapanese Encephalitis Valneva Austria GmbH 2,675
Large-scale testing (Phase 3)Study completedNCT00971425What this trial is testingEvaluation of the Immune Response and the Safety of a Pandemic Influenza Candidate Vaccine (H1N1)Who this might be right forInfluenza GlaxoSmithKline 145